Immune-Assist 247

Immune-Assist 247

Immune Assist 247 je treca generacija imunoloskih suplemenata,  koji sadrzi specijalnu formulu od beta-glukana i polisaharidnih imunostimulativnih jedinjenja dobijenih iz 6 vrsta najpotentnijih medicinskih gljiva uključujući i Alohin Cordyceps, kojima je dodato i retko jedinjenje iz zelenog čaja EGCG( Epigalloceathin Gallate), koji deluju kao imuno modulatori  i koji pomazu da telo ostane jako i vitalno. Namenjen je osobama čiji je imunitet ozbiljno oslabljen, naročito virusnim infekcijama. Takvom imunom sistemu potrebna je jača podrška - 24 sata, sedam dana u nedelji.

Japanski istrazivaci koji su radili na istrazivanju lekova za rak u ranim 1980-tim godinama, otkrili su novu vrstu jedinjenja, koja aktivira veliki broj razlicitih vrsta imununoloskih celija,a cija uloga je borba protiv bakterija, virusa i gljivica, kao i da ociste organizam, unistavajuci celije koje su nadzivele svoj  vek. Ova jedinjenja hetero-polisaharida su potrebna da bi se aktiviralo izbalansirano funkcionisanje imunoloskog sistema. Ranije su ljudi dobijali jedinjenja polisaharida  iz hrane i  probiotika u crevima, ali danas zbog vestackog djubriva i antibiotika koje koristimo mi vise nemamo normalno snabdevanje hranljivih sastojka iz namirnica, sto dovodi do povecane incidence hronicnih oboljenja i bolesti kod ljudi.

Japanski naucnici koji su prvobitno otkrili te imuno modulatore, razvili su proizvode kao sto su AHCC i MGN-3, a te takozvane prve generacije dodataka ishrani za imunitet su tada bili najbolji izbor za podrsku imunoloskom sistemu. Ali od tada je proslo dugih 25 godina i nauka je napredovala, tako da danas imamo mnogo bolja jedinjenja za podrsku nasem imunoloskom sistemu.

Immune Assist 247 je treca generacija imunoloskih suplemenata, koji ima mnogo siri mehanizam  delovanja od bilo kog ranije proizvedenog proizvoda za imunitet. To znaci da je Immune Assist 247  tako formulisan da  aktivira snagu naseg imunoloskog sistema jace od bilo kog proizvoda za imunitet koji danas postoji na trzistu. Mi uglavnom imamao najmanje 260 razlicitih vrsta imunoloskih celija u nasem organizmu, kao sto su T-celije, celije prirodne ubice (NK),  makrofagi... 

Prva generacija koja je napravljena aktivirala je samo jedan tip imunoloskih celija, sto je tada bilo najbolje sto je moglo da se napravi. Ostale imunoloske celije koje postoje u nasem organizmu postoje sa odredjenim  razlogom. Te celije tada nisu mogle da se aktiviraju, jer tadasnja tehnologija i znanje jednostavno nisu bili dovoljni. Da bismo imali optimalno funkcionisuci imunoloski sistem moramo da aktiviramo sve postojece vrste imunoloskih celija, a ne samo jednu vrstu . Na taj nacin dobijamo jak i uravnotezen imunoloski odgovor. Upravo u tom momentu se izdvojio preparat Immune Assist 247 . Koji sada ne aktivira  samo jedan tip celija, vec sadrzi kombinaciju vise od 200 razlicitih hetero-polisaharida (imunoloskih okidaca),koji zajedno sa snaznim antioksidantom EGCG pomazu apsorbciju i aktivaciju tih jedinjenja.

 

  • Prirodni Beta-glukani i sinergisticni izbalansirani imuno metaboliti u Immune Assist-u 247 funkcionisu tako sto pomazu:
  • imunitet mukoze ,
  • povecanje citotoksicnosti prirodnih ubica (NK) celija i T-limfocita,
  • ojacavaju odbrambeni efekat makrofaga,
  • inhibiraju zapaljenje,
  • povecavaju nivo korisnog imunog markera poznatog kao Citokini.

Namenjen je osobama čiji je imunitet ozbiljno oslabljen, naročito virusnim infekcijama. Takvom imunom sistemu potrebna je jača podrška - 24 sata, sedam dana u nedelji. Immune-Assist™ je dodatak ishrani, i koristi se za poboljšanje imunoloskog sistema kod ljudi koji se suočavaju sa ozbiljnim zdravstvenim problemima. 

Immune Assist 247 kao bioloski modifikator organizma  se preporucuje za sve one koji zele da poboljsaju svoj imunitet, a narocito za:

  • hronicno umorne osobe,
  • osobe sa respiratornim infekcijama,
  • osobe koje imaju visok nivo loseg holesterola,
  • obobe koje konzumiraju alkohol u velikim kolicinama,
  • osobe u srednjim ili starijem zivotnom dobu,
  • pusaci i svi oni koji su izlozeni duvanskom dimu,
  • zene koje uzimaju preparate na bazi estrogena,
  • osobe na nekvalitetnoj ishrani ( punoj masne hrane, sa malo voca i povrca).
  • osobe koje su izlozene visokim dozama kancerogenih supstanci,

       Vise nego samo Medicinske gljive.

Immune Assist 247 sadrzi vise od 200 razlicitih imuno modulatornih jedinjenja beta-glukana, ekstrakovanih iz sest razlicitih organskih medicinskih gljiva i retkog jedinjenja iz zelenog caja EGCG( Epigalloceathin Gallate).

Klinicka studija objavljena na MEDLINE  {Effect of immunomodulating and antiviral agent of medicinal mushrooms IMMUNE ASSIST 247 on CD4+ T-lymphocyte counts of HIV-infected patients} je pokazala da Immune Assist 24 7 , kao jedini terapeutski agens bez dodatnih ARV lekova, je sam značajno povećao CD4 + T - limfocite kod svih  pacijenata . Kod jednog pacijenta ,CD4 + T - limfociti su povecani od samo 4 ćelije  na 170 ćelija u 60 dana , što predstavlja povećanje od više od  4000 % Aktivirani citotoksični T limfociti su sada u stanju da postignu dugi i uspešni antitumorksi efekat.

Najveće kliničko testiranje dodatka ishrani za kontrolu HIV-a ikada sprovedeno u svetu: Medline

Nakon saznanja o višestrukim mehanizamima dejstava ove revolucionarne kombinacije, Immune-Assist 247™ izabran je kao jedinjenje koje će se testirati na pacijentima sa ranim stadijumom HIVa-. Noguchi institut iz Akre (Gana), glavni centar za medicinska istraživanja u Africi, odabran je kao glavni saradnik na projektu. Ideja ovog kliničkog testiranja je da se pacijenti čiji je broj T-ćelija veći od 400, drugim rečima, koji su u ranom stadijuma infekcije HIVom, podvrgnu tretmanom Immune-Assist 247™. Smatra se da će svakodnevno korišćenje Immune-Assist 247™, klasifikovanog kao dodatak ishrani a ne lek, usporiti ili zaustaviti napredovanje HIV infekcije. Trenutna praksa u medicini je da se terapija antiretroviralnim lekovima započne tek nakon što broj T-ćelija kod pacijenta padne na 200 i niže. U tom stadijumu pacijent se klasifikuje kao da ima AIDS u punom zamahu i efikasno lečenje je otežano jer je podložan svim mogućim vrstama infekcija. Kod AIDS-a su smrtonosne upravo te infekcije.

Link: Effect of immunomodulating and antiviral agent of medicinal mushrooms (immune assist 24/7) on CD4+ T-lymphocyte counts of HIV-infected patients.

Doziranje i nacin upotrebe

Preporučuje se 3 tablete dnevno. Bilo bi poželjno uzimati sa Vit C u koncentraciji od 2-3 grama jer askorbinska kiselina razbija velike molekule Heteropolysaccharida u manje i samim tim omogucava da se veže za što veći broj imunoloških ćelija organizma. U jednoj bočici ima 90 tableta.



Ovaj tekst i sajt su edukativnog karaktera, namenjeni za opšte obrazovanje i u informativne svrhe, nisu zamena za profesionalni medicinski savet, ispitivanje, dijagnozu ili lečenje.




Nijedan preparat se ne može smatrati lekom već dijeteskim suplementima!

Najčešće postavljena pitanja

Da li je Immune-Assist™ lek?
Ne, Immune-Assist™ je dodatak ishrani, i koristi se za poboljšanje imuno sistema kod ljudi koji se suočavaju sa ozbiljnim zdravstvenim problemima.
Da li Immune-Assist™ mogu svi da koriste?
Da, Immune-Assist™ je bezbedan i prirodan. Svi oni koji žele jači imuni sistem i zdraviji način života mogu da ga koriste kao svakodnevni dodatak ishrani.
Šta je sa ljudima obolelim od raka? Čuo sam da Immune-Assist™ koriste ljudi oboleli od raka koji žele da neutrališu propratne efekte hemoterapije i radijacije. Da li pomaže i u tim slučajevima?
Immune-Assist™ je samo dodatak ishrani, i uprkos onom što ste možda čuli na TVu, radiju ili pročitali u medicinskim časopisima, Immune-Assist™ se ne promoviše kao lek protiv raka. Bez obzira na to kako se Immune-Assist™ koristi u drugim zemljama, u Americi su na snazi čvrsti federalni zakoni koji proizvođaču brane da na bilo koji način sugeriše da Immune-Assist™ može biti koristan dodatak za ljude koji se leče od raka. Rak je ozbiljna bolest, i ako želite da u svoje lečenje uključite i Immune-Assist™, treba o tome da popričate sa svojim lekarom. Biće nam drago da mu damo rezultate svih naših istraživanja.
Da li se Immune-Assist™ pravi u Americi?
Da, Immune-Assist™ se pravi u Americi, korišćenjem isključivo organskih materijala koje je odobrilo Ministarstvo poljoprivrede SADa. Ovo je jedini proizvod te vrste koji se pravi u Americi. Svi ostali imuno suplementi dobijeni iz pečuraka uvoze se sa Orijenta. Premda nemamo ništa protiv dodataka uvezenih iz Kine ili Japana, zar ne bi bilo bolje koristiti potpuno organski američki proizvod sa sertifikatom?
Vidim da druge kompanije tvrde da se njihovi proizvodi dobijaju iz ekstrakta pečuraka iz vrele vode. Da li se Immune-Assist™ pravi od ekstrakata iz tople vode?
Postoje kompanije koje prodaju svoje proizvode putem interneta i koje žele da poverujete da postoji proces koji se zove “ekstrahovanje iz tople vode”. Ovo je odličan marketinški potez, ali termin “ekstrahovanje iz tople vode” znači isto što i “čaj od pečuraka”. Immune-Assist™ se pravi pomoću mnogo složenijeg procesa nego što je ekstrahovanje iz tople vode. Iako proces prečišćavanja koji se koristi kod Immune-Assist™ zaista započinje ekstrahovanjem iz tople vode, on zatim prolazi kroz još nekoliko koraka pomoću kojih se bioaktivna jedinjenja polisaharida razdvajaju, koncentrišu i prečišćavaju, potom se suše, analizira se njihova čistoća, i na kraju se pakuju u kapsule. Potrebno je preko 113 kg šest različitih vrsta svežih medicinskih pečuraka da bi se napravilo pola kile gotovog Immune-Assist™. Gotov Immune-Assist™ sadrži više od 200 različitih vrsta klinički dokazanih polisaharidnih imunomodulaotra.
Šta je sa arabinoksilanom, jedinjenjem koje se nalazi u MGN3? Da li Immune-Assist™ sadrži taj polisaharid?
Da. Immune-Assist™ sadrži ne samo arabinoksilan, već i lentinan, grifolan (prvobitan Maitake D sastojak Dr. Nanbe), PSK i PSP, i aktivno jedinjenje vezano za hemicelulozu (AHCC). U svakoj dozi Immune-Assist™ ima oko tri puta više arabinoksilana nego u MGN3, i četiri puta više AHCC nego kod vodećeg brenda!
Vidim da mnogi dodaci koji iznose tvrdnje zasnovane na testiranjima sprovedenim u laboratorijskim uslovima i onim vršenim na životinjama. Da li je Immune-Assist™ klinički testiran na ljudima, i da li je patentiran i jedinstven na neki drugi način?
Da. Immune-Assist™ je u potpunosti jedinstven i nov tip dodatka ishrani. Testiran je u brojnim kliničkim testiranjima. Testiran je kao pomoćna terapija u konvencionalnom lečenju raka, hepatitisa B, bolestima jetre izazvanim problemima sa alkoholom, a trenutno se testira i za HIV i hepatitis C. Za svako od ovih proučavanja rezultati su zapanjujuće pozitivni. Neke od ovih rezultata kliničkih testiranja možete pogledati i ovde, na vebsajtu kompanije Aloha Medicinals. Pored toga, Immune-Assist™ čeka na patentiranje u SADu i širom sveta.

Aloha Medicinals Inc. je najveći proizvođač imunomodulatora na bazi retkih medicinskih gljiva u svetu. Preparat je registrovan u većini zemalja sveta. 100% proizvedeno u Americi. 100% organiski proizvod. Dijetetski proizvod, apsolutno neškodljiv i nakon dugog uzimanja. Kvalitet aktivne supstance kontroliše vodeća nezavisna laboratorija www.integratedbiomolecule.com

Ovaj tekst i sajt su edukativnog karaktera, namenjeni za opšte obrazovanje i u informativne svrhe, nisu zamena za profesionalni medicinski savet, ispitivanje, dijagnozu ili lečenje.

Nijedan od proizvoda navedenih na ovom sajtu se ne sme smatrati lekom.

Aloha Medicinals Imune Assist 247

Aloha Medicinals Imune Assist Certificates

Aloha Medicinals Imune Assist Certificates

Aloha Medicinals Imune Assist Certificates

Aloha Medicinals Imune Assist Certificates

Aloha Medicinals Imune Assist Certificates

Aloha Medicinals Imune Assist Certificates

 

REFERENCE:

Cancer Research UK
- Medicinal Mushrooms: Their therapeutic properties and current medical usage with special emphasis on cancer treatments:

by

Immune-Assist as an Adjunct for Chemo- and Radiation treatment in Cancer patients

[PDF] Hybridization of Cordyceps sinensis and Quality Analysis - An article on Aloha Medicinals Cordyceps from the "International Journal of Medicinal Mushrooms"

[PDF] On The Trail of the Yak - Most complete article yet on Cordyceps

News Release on Aloha Medicinals Cordyceps

[PDF] Immuno-modulating and Anti-tumor compounds from Medicinal Mushrooms by Dr. Solomon Wasser

[PDF] Medicinal Properties of Substances Occuring in Higher Basidiomycetes Mushrooms: Current Perspective (Review) by Dr. Solomon Wasser

 

Official Government Publication:

Cancer Research UK: Medicinal Mushrooms: Their therapeutic properties and current medical usage with special emphasis on cancer treatments:

by

Table of Contents  (PDF 8.87 kb)



Preamble (PDF 15.5)



Chapter 1 - Introduction (PDF 36.3 kg)



Chapter 2 - The Nature of Fungi with Special Emphasis on Mushrooms  (PDF 1.41 mb)



Chapter 3a - Medicinally Important Mushrooms Part 1  (PDF 8.12 mb)



Chapter 3b - Medicinally Important Mushrooms Part 2  (PDF 8.75)



Chapter 3c - Medicinally Important Mushrooms Part 3  (PDF 8.33)



Chapter 4 - Technology of Mushroom Cultivation (PDF 338 kg)



Chapter 5 - Extraction, Development and Chemistry of Anti-Cancer Compounds from Medicinal Mushrooms (PDF 399 kg)



Chapter 6 - Immunomodulatory Activities of  Mushroom Glucans and Polysaccharide-Protein Complexes in Animals and Humans (PDF 216 kg)



Chapter 7 - The Role of Polysaccharides Derived from Medicinal Mushrooms in Cancer (PDF 133 kg)



Chapter 8 - Additional Medicinal Properties (PDF 84.2 kg)



Chapter 9 - Regulatory and Safety Criteria (PDF 67.8 kg)



Chapter 10 - Conclusions(PDF 49.5 kg)



Appendix 1 - Overview of Human Immune System (PDF 603 kg)



Appendix 2 - Standard Antitumor Activity Test (PDF 12.7 kg)



Appendix 3 - Medicinal Mushrooms and Cancer Prevention (PDF 17.0 kg)



Author Biographies (PDF 21.6 kg)



Executive Summary (PDF 32.7 kg)



Acknowledgment (PDF 6.89 kg)



Front Cover (PDF 6.17 kg)



Back Cover (PDF 26.29 kg)

Ovaj tekst i sajt su edukativnog karaktera, namenjeni za opšte obrazovanje i u informativne svrhe, nisu zamena za profesionalni medicinski savet, ispitivanje, dijagnozu ili lečenje.

Memorial Sloan–Kettering Cancer Center (MSKCC)- Najveci i najstariji u svetu privatan medicinski centar za proucavanje raka sa sedistem u Njujorku.



Cordyceps Sinensis:

  1. Huang KC. The Pharmacology of Chinese Herbs, 2nd ed. Boca Raton: CRC Press; 1999.
  2. Zhu JS, Halpern GM, Jones K. The scientific rediscovery of a precious ancient Chinese herbal regime: Cordyceps sinensis, Part I. J Altern Complement Med 1998;4:289-303.
  3. Zhu JS, Halpern GM, Jones K. The scientific rediscovery of a precious ancient Chinese herbal regime: Cordyceps sinensis, Part II. J Altern Complement Med 1998;4:429-57.
  4. Xu F, et al. Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney-transplant recipients. Nephrol Dial Transplant 1995;10:142-3.
  5. Huang B, et al. Cordyceps sinensis and its fractions stimulate MA-10 mouse Leydig tumor cell steroidogenesis. J Androl 2001;22:831-7.
  6. Nakamura K, et al. Inhibitory effect of Cordyceps sinensis on spontaneous liver metastasis of Lewis lung carcinoma and B16 melanoma cells in syngeneic mice. Jpn J Pharmacol 1999;79:335-41.
  7. Chiu JH, et al. Cordyceps sinensis increases the expression of major histocompatibility complex class II antigens in human hepatoma cell line HA22T/VGH cells. Am J Chin Med 1998;26:59-70.
  8. Li, Y. et. al. Effect of Cordyceps sinensis on erythropoiesis in mouse bone marrow. Chin Med J (Engl). 1993 Apr;106(4):313-6.
  9. Huang YL, Leu SF, Liu BC, et al. In vivo stimulatory effect of Cordyceps sinensis mycelium and its fractions on reproductive functions in male mouse. Life Sci 2004 Jul 16;75(9):1051-62.
  10. Wu WC, Hsiao JR, Lian YY, et al. The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemother Pharmacol. 2007 Jun;60(1):103-11.
  11. Oh JY, Baek YM, Kim SW, et al. Apoptosis of human hepatocarcinoma (HepG2) and neuroblastoma (SKN-SH) cells induced by polysaccharides-peptide complexes produced by submerged mycelial culture of an entomopathogenic fungus Cordyceps sphecocephala. J Microbiol Biotechnol. 2008 Mar;18(3):512-9.
  12. Liu WC, Wang SC, Tsai ML, et al. Protection against radiation-induced bone marrow and intestinal injuries by Cordyceps sinensis, a Chinese herbal medicine. Radiat Res. 2006 Dec;166(6):900-7.
  13. Liu WC, Chuang WL, Tsai ML, et al. Cordyceps sinensis health supplement enhances recovery from taxol-induced leukopenia. Exp Biol Med (Maywood). 2008 Apr;233(4):447-55.
  14. Kubo E, Yoshikawa N, Kunitomo M, et al. Inhibitory effect of Cordyceps sinensis on experimental hepatic metastasis of melanoma by suppressing tumor cell invasion. Anticancer Res. 2010 Sep;30(9):3429-33.
  15. Lo HC, Hsu TH, Tu ST, Lin KC. Anti-hyperglycemic activity of natural and fermented Cordyceps sinensis in rats with diabetes induced by nicotinamide and streptozotocin. Am J Chin Med. 2006;34(5):819-32.
  16. Shi B, Wang Z, Jin H, et al. Immunoregulatory Cordyceps sinensis increases regulatory T cells to Th17 cell ratio and delays diabetes in NOD mice. Int Immunopharmacol. 2009 May;9(5):582-6.
  17. Ji NF, Yao LS, Li Y, et al. Polysaccharide of Cordyceps sinensis Enhances Cisplatin Cytotoxicity in Non-Small Cell Lung Cancer H157 Cell Line. Integr Cancer Ther. 2011;10(4):359-67.
  18. Zhang Z, Wang X, Zhang Y, Ye G. Effect of Cordyceps sinensis on Renal Function of Patients with Chronic Allograft Nephropathy. Urol Int. 2011;86(3):298-301.

     

Coriolus Versicolor

  1. Nakazato H, et al. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet 1994; 343(8906): 1122-6.
  2. Niimoto M, et al. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years. Jpn J Surg 1988; 18(6): 681-6.
  3. Ohwada S, et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer 2004; 90(5): 1003-10.
  4. Mitomi T, et al. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Dis Colon Rectum 1992; 35(2): 123-30.
  5. Torisu M, et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 1990; 31(5): 261-8.
  6. Tsang KW, et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med 2003; 97(6): 618-24.
  7. Wong CK, et al. Immunomodulatory effects of yun zhi and danshen capsules in health subjects—a randomized, double-blind, placebo-controlled, crossover study. Int Immunopharmacol 2004; 4(2): 201-11.
  8. Wong CK, et al. Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 2005; 33(3): 381-95.
  9. Iino Y, et al. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. Anticancer Res 1995; 15(6B): 2907-11.
  10. Suto T, et al. Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma. Cancer Chemother Pharmacol 1994; 33: S145-8.
  11. Ohno R, et al. A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation. Cancer Immunol Immunother 1984; 18(3): 149-54.
  12. Toth B, Coles M, Lynch J. Effects of VPS extract of Coriolus versicolor on cancer of the large interstine using a serial sacrifice technique. In Vivo 2006;20(3):341-6.
  13. Yang X, et al. The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells. Oncol Rep 2005; 13(6): 1201-10.
  14. Wan JMF, Sit WH, Yang X, Jiang P, Wong LY. Polysaccharopeptides derived from Coriolus versicolor potentiate the S-phase specific cytotoxicity of Camptothecin (CPT) on human leukemia HL-60 cells. Chinese Medicine. 2010;5:16.
  15. Jiang J, Sliva D. Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. Int J Oncol. 2010 Dec;37(6):1529-36.
  16. Collins RA, Ng TB. Polysaccharopeptide from Coriolus versicolor has Potential for Use Against Human Immunodeficiency Virus type I Infection. Pharmcology Letters 1997; 60(25): 387-387.
  17. Tsukagoshi S, et al. Krestin (PSK). Cancer Treat Rev 1984; 11(2): 131-55.
  18. Liu WK, et al. Activation of peritoneal macrophages by polysaccharopeptide from the mushroom, Coriolus versicolor. Immunopharmacology 1993; 26(2): 139-46.
  19. Ng TB, Chan WY. Polysaccharopeptide from the mushroom Coriolus versicolor possesses analgesic activity but does not produce adverse effects on female reproductive or embryonic development in mice. Gen Pharmacol 1997; 29(2): 269-73.
  20. Kato M, et al. Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide. Cancer Immunol Immunother 1995; 40(3): 152-6.
  21. Shiu WCT, et al. A Clinical Study of PSP on Peripheral Blood Counts during Chemotherapy. Phytotherapy Research 1992; (6): 217-218.
  22. Kidd, PM. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 2000 5(1): 4-27.
  23. Lau CB, et al. Cytotoxic activities of Coriolus versicolor (Yunzhi) extract on human leukemia and lymphoma cells by induction of apoptosis. Life Sci 2004; 75(7): 797-808.
  24. Hirahara N, Edamatsu T, Fujieda A, et al. Protein-bound polysaccharide-K (PSK) induces apoptosis via p38 mitogen-activated protein kinase pathway in promyelomonocytic leukemia HL-60 cells. Anticancer Res. 2012 Jul;32(7):2631-7.

Agaricus Blazei

    1. Fujimiya Y, Suzuki Y, Oshiman K, et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunol Immunother. May 1998;46(3):147-159.
    2. Itoh H, Ito H, Amano H, et al. Inhibitory action of a (1—>6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill (“himematsutake”) on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Jpn J Pharmacol. Oct 1994;66(2):265-271.
    3. Kimura Y, Kido T, Takaku T, et al. Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions. Cancer Sci. Sep 2004;95(9):758-764.
    4. Lee YL, Kim HJ, Lee MS, et al. Oral administration of Agaricus blazei (H1 strain) inhibited tumor growth in a sarcoma 180 inoculation model. Exp Anim. Oct 2003;52(5):371-375.
    5. Mizuno M, Morimoto M, Minato K, et al. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotechnol Biochem. Mar 1998;62(3):434-437.
    6. Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr. May 2001;131(5):1409-1413.
    7. Ahn WS, Kim DJ, Chae GT, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer. Jul-Aug 2004;14(4):589-594.
    8. Gray AM, Flatt PR. Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J Endocrinol. May 1998;157(2):259-266.
    9. Swanston-Flatt SK, Day C, Flatt PR, et al. Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res. Feb 1989;10(2):69-73.
    10. Kim YW, Kim KH, Choi HJ, et al. Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnol Lett. Apr 2005;27(7):483-487.
    11. Hsu CH, Liao YL, Lin SC, et al. The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. J Altern Complement Med. Jan-Feb 2007;13(1):97-102.
    12. Liu Y, Fukuwatari Y, Okumura K, et al. Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers. Evid Based Complement Alternat Med. Jun 2008;5(2):205-219.
    13. Hsu CH, Hwang KC, Chiang YH, et al. The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B. J Altern Complement Med. Apr 2008;14(3):299-301.
    14. Mukai H, Watanabe T, Ando M, et al. An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients. Jpn J Clin Oncol. Dec 2006;36(12):808-810.
    15. Suehiro M, Katoh N, Kishimoto S. Cheilitis due to Agaricus blazei Murill mushroom extract. Contact Dermatitis. May 2007;56(5):293-294.
    16. Dong S, Furutani Y, Suto Y, et al. Estrogen-like activity and dual roles in cell signaling of an Agaricus blazei Murrill mycelia-dikaryon extract. Microbiol Res. Oct 17 2011.
    17. Takimoto H, Wakita D, Kawaguchi K, et al. Potentiation of cytotoxic activity in naive and tumor-bearing mice by oral administration of hot-water extracts from Agaricus brazei fruiting bodies. Biol Pharm Bull. Mar 2004;27(3):404-406.
    18. Yuminamochi E, Koike T, Takeda K, et al. Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill. Immunology. Jun 2007;121(2):197-206.
    19. Gao L, Sun Y, Chen C, et al. Primary mechanism of apoptosis induction in a leukemia cell line by fraction FA-2-b-ss prepared from the mushroom Agaricus blazei Murill. Braz J Med Biol Res. Nov 2007;40(11):1545-1555.
    20. Jin CY, Moon DO, Choi YH, et al. Bcl-2 and caspase-3 are major regulators in Agaricus blazei-induced human leukemic U937 cell apoptosis through dephoshorylation of Akt. Biol Pharm Bull. Aug 2007;30(8):1432-1437.
    21. Su ZY, Tung YC, Hwang LS, et al. Blazeispirol A from Agaricus blazei fermentation product induces cell death in human hepatoma Hep 3B cells through caspase-dependent and caspase-independent pathways. J Agric Food Chem. May 11 2011;59(9):5109-5116.
    22. Akiyama H, Endo M, Matsui T, et al. Agaritine from Agaricus blazei Murrill induces apoptosis in the leukemic cell line U937. Biochim Biophysica Acta. May 2011;1810(5):519-525.
    23. Engdal S, Nilsen OG. In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients. Phytother Res. 2009 Jul;23(7):906-12.
    24. Lee JS, Hong EK. Agaricus blazei Murill enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells by NFκB-mediated increase of intracellular doxorubicin accumulation. Int J Oncol. 2011 Feb;38(2):401-8.

    25. Lima CU, Souza VC, Morita MC, Chiarello MD, Karnikowski MG. Agaricus blazei Murrill and inflammatory mediators in elderly women: a randomized clinical trial. Scand J Immunol. 2012 Mar;75(3):336-41.

    Inonotus Obliquus /Chaga/

    1. ^ "Inonotus obliquus (Ach. ex Pers.) Pilát 1942". MycoBank. International Mycological Association. Retrieved 2011-10-11.
    2. ^ Needham, Arthur (2005-12-16). "Clinker Polypore, Chaga". Retrieved 10 October 2011.
    3. ^ Muma, Walter. "True Tinder Fungus". Retrieved 5 December 2012.
    4. ^ Youn, Myung-Ja; Kim, JK; Park, SY; Kim, Y; Kim, SJ; Lee, JS; Chai, KY; Kim, HJ; Cui, MX; So, HS; Kim, KY; Park, R (2008). "Chaga mushroom (Inonotus obliquus ) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells". World Journal of Gastroenterology 14 (4): 511–7. doi:10.3748/wjg.14.511. PMC 2681140. PMID 18203281.
    5. ^ "Chaga Mushroom". Memorial Sloan–Kettering Cancer Center. 18 July 2011. Retrieved August 2013.
    6. ^
      • Rzymowska, J (1998). "The effect of aqueous extracts from Inonotus obliquus on the mitotic index and enzyme activities". Bollettino chimico farmaceutico 137 (1): 13–5. PMID 9595828.
      • Mizuno, Takashi; Zhuang, Cun; Abe, Kuniaki; Okamoto, Hidehumi; Kiho, Tadashi; Ukai, Shigeo; Leclerc, Sophie; Meijer, Laurent (1999). "Antitumor and Hypoglycemic Activities of Polysaccharides from the Sclerotia and Mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae)". International Journal of Medicinal Mushrooms 1 (4): 301. doi:10.1615/IntJMedMushr.v1.i4.20.
    7. ^ Cui, Y; Kim, DS; Park, KC (2005). "Antioxidant effect of Inonotus obliquus". Journal of ethnopharmacology 96 (1–2): 79–85. doi:10.1016/j.jep.2004.08.037. PMID 15588653.
    8. ^
      • Kim, Yong Ook; Han, Sang Bae; Lee, Hong Woen; Ahn, Hyo Jung; Yoon, Yeo Dae; Jung, Joon Ki; Kim, Hwan Mook; Shin, Chul Soo (2005). "Immuno-stimulating effect of the endo-polysaccharide produced by submerged culture of Inonotus obliquus". Life Sciences 77 (19): 2438–56. doi:10.1016/j.lfs.2005.02.023. PMID 15970296.
      • Kim, Yong Ook; Park, Hae Woong; Kim, Jong Hoon; Lee, Jae Young; Moon, Seong Hoon; Shin, Chul Soo (2006). "Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus". Life Sciences 79 (1): 72–80. doi:10.1016/j.lfs.2005.12.047. PMID 16458328.
    9. ^
      • Park, Young-Mi; Won, Jong-Heon; Kim, Yang-Hee; Choi, Jong-Won; Park, Hee-Juhn; Lee, Kyung-Tae (2005). "In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus". Journal of Ethnopharmacology 101 (1–3): 120–8. doi:10.1016/j.jep.2005.04.003. PMID 15905055.
      • Mishra, Siddhartha Kumar; Kang, Ju-Hee; Kim, Dong-Kyu; Oh, Seung Hyun; Kim, Mi Kyung (2012). "Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice". Journal of Ethnopharmacology 143 (2): 524–32. doi:10.1016/j.jep.2012.07.008. PMID 22819687.
    10. ^ a b Zheng, W. F.; Liu, T.; Xiang, X. Y.; Gu, Q. (July 2007). "Sterol composition in field-grown and cultured mycelia of Inonotus obliquus". Yao xue xue bao = Acta pharmaceutica Sinica 42 (7): 750–756. PMID 17882960.
    11. ^ Zheng W, Miao K, Liu Y, Zhao Y, Zhang M, Pan S et al. (2010). "Chemical diversity of biologically active metabolites in the sclerotia of Inonotus obliquus and submerged culture strategies for up-regulating their production". Appl Microbiol Biotechnol 87 (4): 1237–54. doi:10.1007/s00253-010-2682-4. PMID 20532760.
    12. ^ Zheng, W. F. (July 2008). "Phenolic compounds from Inonotus obliquus and their immune-stimulating effects". Mycosystema 27 (4): 574–581.
    13. ^ Müllauer, Franziska (2011). Betulinic Acid Induced Tumor Killing.
    14. ^ a b Paper with background on extraction processes
    15. ^ Rhee, S.Y. (2008). "A comparative study of analytical methods for alkali-soluble β-glucan in medicinal mushroom, Chaga (Inonotus obliquus)". LWT - Food Science and Technology 41 (3): 545–549.
    16. Smith JE, Rowan NJ, Sullivan R Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatments, 2001
    17. Cristina Lull, Harry J. Wichers, and Huub F. J. Savelkoul "Antiinflammatory and Immunomodulating Properties of Fungal Metabolites", Wageningen University and Research Center, The Netherlands 2005
    18. Ulrike Lindequist, Timo H. J. Niedermeyer, and Wolf-Dieter Jülich " The Pharmacological Potential of Mushrooms", Oxford University Press 2005
    19. Andrea T. Borchers, Anita Krishnamurthy, Carl L. Keen, Frederick J. Meyersà, and M. Eric Gershwin "Immunobiology of Mushrooms", Society for Experimental Biology and Medicine 2008